Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile
Clarify Health
MAY 19, 2020
sales, medical science liaisons, etc.). As healthcare providers (HCPs) are re-deployed to care for COVID-19 patients, many chronically-ill patients will have less frequent follow-up with their doctors. Biopharma brand teams will need to adjust their expectations around product adoption in light of this new normal.
52 
Let's personalize your content